Treatment of Post-COVID-19 Encephalitis

Immediate Diagnostic and Treatment Algorithm

The American Academy of Neurology recommends initiating intravenous acyclovir 10 mg/kg every 8 hours immediately upon suspicion of encephalitis following COVID-19, while simultaneously pursuing comprehensive diagnostic workup to differentiate viral from autoimmune etiologies 1, 2
The Infectious Diseases Society of America suggests that HSV and VZV encephalitis can occur as opportunistic infections in the post-COVID immunocompromised state, making empiric treatment critical 3, 4

The Centers for Disease Control and Prevention recommend that CSF analysis must include broader pathogen testing than standard encephalitis workup, including mandatory PCR for HSV-1, HSV-2, VZV, enteroviruses, EBV, and CMV 3, 4
The World Health Organization suggests that SARS-CoV-2 RT-PCR on CSF should be performed, as it can remain positive despite negative nasopharyngeal swabs 1

The Infectious Diseases Society of America recommends continuing IV acyclovir for a minimum of 21 days in confirmed viral encephalitis in post-COVID patients, with repeat lumbar puncture and CSF PCR at completion of therapy to confirm viral clearance 3, 4

The National Institute of Neurological Disorders and Stroke suggests that IV methylprednisolone or oral prednisone may be used in cases of confirmed direct SARS-CoV-2 CNS infection, although the evidence base is limited 1
The American Academy of Neurology recommends considering IV immunoglobulin (IVIG) in cases of COVID-19 encephalitis, as it may mitigate cytokine storm and secondary vasogenic edema 1

The American College of Rheumatology suggests that post-COVID patients may have prolonged immunosuppression due to lymphopenia and T-cell dysfunction from acute COVID-19, corticosteroid use during COVID-19 treatment, underlying conditions requiring immunosuppression, and recent cellular therapy or transplantation 5, 6
The American Heart Association recommends initiating venous thromboembolism prophylaxis in post-COVID patients with encephalitis, as both COVID-19 and encephalitis increase thrombotic risk 1, 5

The American Academy of Neurology suggests treating seizures with antiepileptic drugs, such as levetiracetam, and using EEG monitoring to identify non-convulsive seizures in confused or comatose patients 1, 2

The Society of Critical Care Medicine recommends that all patients with post-COVID-19 encephalitis require hospitalization with ICU access, and that falling level of consciousness demands urgent ICU assessment for airway protection and management of elevated intracranial pressure 2, 7

The American Academy of Neurology recommends that all patients require rehabilitation assessment regardless of age, and that outpatient follow-up should be organized with plans for continued suppressive therapy if immunocompromised 2, 4